FR2784383B1 - Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53 - Google Patents

Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53

Info

Publication number
FR2784383B1
FR2784383B1 FR9812754A FR9812754A FR2784383B1 FR 2784383 B1 FR2784383 B1 FR 2784383B1 FR 9812754 A FR9812754 A FR 9812754A FR 9812754 A FR9812754 A FR 9812754A FR 2784383 B1 FR2784383 B1 FR 2784383B1
Authority
FR
France
Prior art keywords
interacting
protein
polypeptides capable
oncogenic mutants
oncogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9812754A
Other languages
English (en)
Other versions
FR2784383A1 (fr
Inventor
Emmanuel Conseiller
Laurent Debussche
William Gallagher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9812754A priority Critical patent/FR2784383B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to CA002347121A priority patent/CA2347121A1/fr
Priority to AU60958/99A priority patent/AU6095899A/en
Priority to JP2000576010A priority patent/JP2002527063A/ja
Priority to EP99947556A priority patent/EP1121427A1/fr
Priority to PCT/FR1999/002465 priority patent/WO2000022120A1/fr
Publication of FR2784383A1 publication Critical patent/FR2784383A1/fr
Priority to US09/829,936 priority patent/US20030049699A1/en
Application granted granted Critical
Publication of FR2784383B1 publication Critical patent/FR2784383B1/fr
Priority to US10/759,256 priority patent/US20050129698A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9812754A 1998-10-12 1998-10-12 Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53 Expired - Fee Related FR2784383B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9812754A FR2784383B1 (fr) 1998-10-12 1998-10-12 Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53
AU60958/99A AU6095899A (en) 1998-10-12 1999-10-12 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein
JP2000576010A JP2002527063A (ja) 1998-10-12 1999-10-12 ｐ５３タンパク質の発癌性突然変異体と相互作用することが可能な（ＭＢＰ１）ポリペプチド
EP99947556A EP1121427A1 (fr) 1998-10-12 1999-10-12 Polypeptide (mbp1) capable d'interagir avec les mutants oncogeniques de la proteine p53
CA002347121A CA2347121A1 (fr) 1998-10-12 1999-10-12 Polypeptides (mbp1) capables d'interagir avec les mutants oncogeniques de la proteine p53
PCT/FR1999/002465 WO2000022120A1 (fr) 1998-10-12 1999-10-12 Polypeptides (mbp1) capables d'interagir avec les mutants oncogeniques de la proteine p53
US09/829,936 US20030049699A1 (en) 1998-10-12 2001-04-11 Polypeptide (MBP1) capable of interacting with oncogenic mutants of the P53 protein
US10/759,256 US20050129698A1 (en) 1998-10-12 2004-01-20 Polypeptides (MBP1) capable of interacting with oncogenic mutants of the p53 protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812754A FR2784383B1 (fr) 1998-10-12 1998-10-12 Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53

Publications (2)

Publication Number Publication Date
FR2784383A1 FR2784383A1 (fr) 2000-04-14
FR2784383B1 true FR2784383B1 (fr) 2003-02-07

Family

ID=9531448

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9812754A Expired - Fee Related FR2784383B1 (fr) 1998-10-12 1998-10-12 Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53

Country Status (2)

Country Link
US (1) US20050129698A1 (fr)
FR (1) FR2784383B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5132405A (en) * 1987-05-21 1992-07-21 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
DE3856559T2 (de) * 1987-05-21 2004-04-29 Micromet Ag Multifunktionelle Proteine mit vorbestimmter Zielsetzung
JP2000508894A (ja) * 1996-04-10 2000-07-18 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド 細胞外／上皮増殖因子ｈｃａｂａ５８ｘ

Also Published As

Publication number Publication date
US20050129698A1 (en) 2005-06-16
FR2784383A1 (fr) 2000-04-14

Similar Documents

Publication Publication Date Title
IL133604A0 (en) Fused 1, 2, 4-thiadiazine derivatives, their preparation and use
DE69833224D1 (en) Benzothiazole als protein tyrosin-kinase inhibitoren
FR2795304B1 (fr) Ensemble prothetique d'articulation de l'epaule
PT1300174E (pt) ''kit'' de introducao de implante
HUP0200414A2 (en) Interferon-betha fusion proteins and uses
DE69812606D1 (de) Künstliche körperflüssigkeit
FR2758377B1 (fr) Bague d'etancheite coaxiale
PL338144A1 (en) Derivatives of dolastatin 15
AU1932097A (en) Upper body garment
FR2743717B1 (fr) Prothese d'articulation phalangienne
IL140509A0 (en) Expression of functional eukaryotic proteins
FR2763953B1 (fr) Derives de 5'-desoxy-cytidine
AU2327100A (en) Cement-based joint body and joint material therefor
FR2755847B1 (fr) Ensemble prothetique pour l'articulation de l'epaule
FR2767674B1 (fr) Prothese de l'extremite superieure de l'humerus
FR2780974B1 (fr) Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
PT1060183E (pt) Derivados de 5'-desoxicitidina
PL350181A1 (en) Caspase−8 interacting proteins
FR2740325B1 (fr) Prothese de l'articulation femoro-patellaire
FR2784383B1 (fr) Polypeptides capables d'interagir avec les mutants oncogeniques de la proteine p53
DK1051487T3 (da) Placentaprotein 13
IL143052A0 (en) Mammalian chondromodulin-like protein
MD145B1 (ro) Bautura de tip brendi "botna"
AU6164099A (en) Hrpca 9 and hrpca 10 nucleic acids and polypeptides
AUPP172398A0 (en) Upper body garment

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20110630